Cargando…
Targeting Persistent Human Papillomavirus Infection
While the majority of Human papillomavirus (HPV) infections are transient and cleared within a couple of years following exposure, 10–20% of infections persist latently, leading to disease progression and, ultimately, various forms of invasive cancer. Despite the clinical efficiency of recently deve...
Autores principales: | Shanmugasundaram, Srinidhi, You, Jianxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5580486/ https://www.ncbi.nlm.nih.gov/pubmed/28820433 http://dx.doi.org/10.3390/v9080229 |
Ejemplares similares
-
Persistent Human Papillomavirus Infection
por: Della Fera, Ashley N., et al.
Publicado: (2021) -
Human Papillomaviruses Target the DNA Damage Repair and Innate Immune Response Pathways to Allow for Persistent Infection
por: Gusho, Elona, et al.
Publicado: (2021) -
Immune Dysregulation in Patients Persistently Infected with Human Papillomaviruses 6 and 11
por: Lucs, Alexandra V., et al.
Publicado: (2015) -
Genetic Predisposition to Persistent Human Papillomavirus-Infection and Virus-Induced Cancers
por: Espinoza, Helen, et al.
Publicado: (2021) -
The Reservoir of Persistent Human Papillomavirus Infection; Strategies for Elimination Using Anti-Viral Therapies
por: Zheng, Ke, et al.
Publicado: (2022)